Skip to content

Drug interactions

Selexipag + Sunitinib

Severity: Minor

Selexipag and Sunitinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sunitinib may inhibit BCRP and raise exposure of selexipag or its active metabolite. This could increase prostacyclin-related effects such as headache, hypotension and diarrhea.

What this interaction means in plain words

Selexipag and Sunitinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Selexipag belongs to Cardiovascular; Sunitinib belongs to Oncology.

Evidence level: Low

Why it happens

Possible inhibition of BCRP-mediated efflux of selexipag by sunitinib.

What to do

Monitor for prostacyclin-related adverse effects and blood pressure, reducing selexipag dose if poorly tolerated.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Selexipag and Sunitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Selexipag with Sunitinib?

MediHelp rates the interaction as minor. Selexipag and Sunitinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Sunitinib may inhibit BCRP and raise exposure of selexipag or its active metabolite. This could increase prostacyclin-related effects such as headache, hypotension and diarrhea.

How serious is the interaction between Selexipag and Sunitinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for prostacyclin-related adverse effects and blood pressure, reducing selexipag dose if poorly tolerated.

What other medicines interact with Sunitinib?

MediHelp also lists interactions of Sunitinib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sunitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in